Recent Finacing
Recent Raise
Remedium Bio develops a Prometheus adjustable gene-therapy platform for localized subcutaneous delivery allowing post-treatment dose adjustment to replace repeat protein injections, with programs in osteoarthritis, diabetes, neurology, and immunology.
